BMJ supportive & palliative care · 2026
Cancer patient navigation: program development in a large multisite cancer institute (2010-2023).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Blackley Kris, Lasheen Wael, Walsh Declan, Wise Cindy, Hess Elizabeth, Crump Brenda, Kabrich Laura
Аннотация
OBJECTIVE: This paper outlines the 13-year development of a comprehensive, multisite patient navigation (PN) programme at Atrium Health Levine Cancer Institute (LCI), aiming to inform institutions seeking to establish or expand navigation services.
METHODS: Between 2010 and 2023, LCI's PN programme evolved through three distinct phases: initiation, structured development and system-wide consolidation. Key components included appointing a programme director, introducing the Acuity Grading Scale for patient prioritisation, integrating PN documentation into the electronic medical record and developing operational policies aligned with Commission on Cancer standards. Both generalist and tumour-specific nurse navigators were employed across urban and rural settings, supplemented by virtual navigation services.
RESULTS: The programme demonstrated improved care coordination, timely treatment initiation and equitable access, particularly among racial and ethnic minorities. Virtual navigation proved effective during the COVID-19 pandemic. Challenges included securing clinician buy-in, standardising services across cancer types and sustaining funding amid limited reimbursement models. A navigator academy and ongoing competency evaluations supported workforce development.
CONCLUSIONS: LCI's experience offers a replicable model for building PN programmes grounded in standardisation, community needs and workforce training. While promising, broader adoption will require further evidence-based standards, financial modelling and strategies to navigate system integration challenges.
METHODS: Between 2010 and 2023, LCI's PN programme evolved through three distinct phases: initiation, structured development and system-wide consolidation. Key components included appointing a programme director, introducing the Acuity Grading Scale for patient prioritisation, integrating PN documentation into the electronic medical record and developing operational policies aligned with Commission on Cancer standards. Both generalist and tumour-specific nurse navigators were employed across urban and rural settings, supplemented by virtual navigation services.
RESULTS: The programme demonstrated improved care coordination, timely treatment initiation and equitable access, particularly among racial and ethnic minorities. Virtual navigation proved effective during the COVID-19 pandemic. Challenges included securing clinician buy-in, standardising services across cancer types and sustaining funding amid limited reimbursement models. A navigator academy and ongoing competency evaluations supported workforce development.
CONCLUSIONS: LCI's experience offers a replicable model for building PN programmes grounded in standardisation, community needs and workforce training. While promising, broader adoption will require further evidence-based standards, financial modelling and strategies to navigate system integration challenges.